Cell therapy sector surges, Zhaoyan New Drug hits the daily limit

MaticHoleFiller

2026-03-27 12:34:06

Abstract generation in progress

March 27 news, as of 10:45, the cell therapy sector surged, with Zhaoyang New Drugs and Shuanglu Pharmaceutical reaching the daily limit, while stocks such as Tailin Bio and Hansoh Pharmaceuticals saw leading gains.

Statement: The market involves risks, and investment requires caution. This article is automatically published based on third-party databases and does not represent Sina Finance’s viewpoints. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there is any discrepancy, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

Massive information and precise insights—only on the Sina Finance app

责任编辑：小浪快报

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.